Inherited risk factors for venous thromboembolism (Q38178063)

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of venous thrombosis in patients with major illnesses: results from the MEGA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Familial risk of venous thromboembolism: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Venous thrombosis: a multicausal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Deficiency of protein C in congenital thrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Antithrombin: a new look at the actions of a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The anticoagulant protein C pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Prevalence of antithrombin deficiency in the healthy population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Molecular genetics of antithrombin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Absence of thrombosis in subjects with heterozygous protein C deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Regulation of TFPI function by protein S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Functional characterization of recombinant FV Hong Kong and FV Cambridge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Epidemiology of factor V Leiden: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Elevated factor VIII levels and risk of venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The haemostatic role of tissue factor pathway inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

F9 Malmö, factor IX and deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

X-linked thrombophilia with a mutant factor IX (factor IX Padua).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Low risk of thrombosis in family members of patients with hyperhomocysteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genome scan of venous thrombosis in a pedigree with protein C deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Past and future of genetic research in thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Updated analysis of gene variants associated with deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genetics of venous thrombosis: insights from a new genome wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Prioritizing GWAS results: A review of statistical methods and recommendations for their application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Molecular genetic studies of complex phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombosis of the cerebral veins and sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Hyperhomocysteinemia in cerebral vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Stroke in pregnancy and the puerperium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Abdominal thromboses of splanchnic, renal and ovarian veins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The burden of disease of retinal vein occlusion: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Does thrombophilia testing help in the clinical management of patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genetic testing and common disorders in a public health framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombophilia, clinical factors, and recurrent venous thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Postmenopausal hormone replacement therapy and venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Practice bulletin no. 124: inherited thrombophilias in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Recommendations for the prevention of pregnancy-associated venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Advances in laboratory testing for thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Validated questionnaire for the identification of previous personal or familial venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

ABO Blood Group and von Willebrand Factor Levels Partially Explained the Incomplete Penetrance of Congenital Thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Vascular disorders of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Prevalence of Factor IX-R338L (Factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Incidence and mortality of venous thrombosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Rare thromboses of cerebral, splanchnic and upper-extremity veins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Familial segregation of venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The value of family history as a risk indicator for venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The familial tendency in thrombo-embolic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Inherited Antithrombin Deficiency Causing Thrombophilia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Molecular basis of protein S deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Three new cases of dysfibrinogenemia: Poissy III, Saint-Germain I and Tahiti.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

A database for human fibrinogen variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

High levels of coagulation factor XI as a risk factor for venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Gene variants associated with deep vein thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Factor IX-R338L (Factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Thrombosis from a prothrombin mutation conveying antithrombin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Mechanisms of the factor V Leiden paradox

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk factors for thrombophilia in extrahepatic portal vein obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The G20210A prothrombin gene mutation: is there room for screening families?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Mutant factor V (Arg506Gln) in healthy centenarians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Recurrence rate after a first venous thrombosis in patients with familial thrombophilia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Sex difference in risk of second but not of first venous thrombosis: paradox explained

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.211

Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood.

31 March 2020

1 reference

12 December 2020

A novel prothrombin mutation in two families with prominent thrombophilia--the first cases of antithrombin resistance in a Caucasian population

1 reference

12 December 2020

Laboratory diagnosis of dysfibrinogenemia

1 reference

12 December 2020

Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis

1 reference

12 December 2020

Venous thrombotic risk in family members of unselected individuals with factor V Leiden

1 reference

12 December 2020

Hyperhomocysteinemia and thrombosis: an overview

1 reference

12 December 2020

Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale

1 reference

12 December 2020

The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1

1 reference

12 December 2020

Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

1 reference

12 December 2020

Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency

1 reference

12 December 2020

High levels of factor IX increase the risk of venous thrombosis

1 reference

12 December 2020

Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings

1 reference

12 December 2020

Molecular basis of protein S deficiency.

1 reference

12 December 2020

INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA

1 reference

12 December 2020

Inherited thrombophilia: Part 1

1 reference

12 December 2020

Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460.

1 reference

12 December 2020

Prevalence of protein C deficiency in the healthy population

1 reference

12 December 2020

Thrombosis in pregnancy: updates in diagnosis and management

1 reference

12 December 2020

The Leiden Thrombophilia Study (LETS)

1 reference

12 December 2020

Familial clustering of factor VIII and von Willebrand factor levels

1 reference

12 December 2020

Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates

1 reference

12 December 2020

Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

A novel mutation of Arg306 of factor V gene in Hong Kong Chinese

1 reference

12 December 2020

Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein

1 reference

12 December 2020

Hormone therapy and thromboembolic disease

1 reference

12 December 2020

Systematic review: family history in risk assessment for common diseases

1 reference

12 December 2020

Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease

1 reference

12 December 2020

The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.

1 reference

12 December 2020

Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C

1 reference

12 December 2020

High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

1 reference

12 December 2020

Geographic distribution of the 20210 G to A prothrombin variant

1 reference

12 December 2020

Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis

1 reference

12 December 2020

Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH

1 reference

12 December 2020

Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes.

1 reference

12 December 2020

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

1 reference

12 December 2020

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis

1 reference

12 December 2020

ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia

1 reference

12 December 2020

Plasma protein S deficiency in familial thrombotic disease

1 reference

12 December 2020

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study

1 reference

12 December 2020

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism

1 reference

12 December 2020

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)

1 reference

12 December 2020

Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.

1 reference

12 December 2020

Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.

1 reference

12 December 2020

The effect of ABO blood group on the diagnosis of von Willebrand disease.

1 reference

12 December 2020

Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis

1 reference

12 December 2020

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

1 reference

12 December 2020

Inhibition of activated protein C anticoagulant activity by prothrombin

1 reference

12 December 2020

The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study

1 reference

12 December 2020

Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families

1 reference

12 December 2020

Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene

1 reference

12 December 2020

Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S

1 reference

12 December 2020

Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S

1 reference

12 December 2020

Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation

1 reference

12 December 2020

Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases

1 reference

12 December 2020

Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.

1 reference

12 December 2020

Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency

1 reference

12 December 2020

Genetic risk factors for superficial vein thrombosis

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S

1 reference

12 December 2020

Incidence of venous thromboembolism in families with inherited thrombophilia

1 reference

12 December 2020

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies

1 reference

12 December 2020